Cart (0 Items)
Your cart is currently empty.
View ProductsAntibody production
-
Antibody productionMastering Hybridoma Technology: The Future of Monoclonal Antibodies in Research and Medicine
Thomas Meyer
Scientists and researchers in fields spanning from healthcare and biotechnology to agricultural sciences have long sought reliable methods to produce highly specific and consistent antibodies. Imagine you are a researcher…
-
Unleashing the Future of Therapeutic Antibody Innovation
Imagine you're a scientist on the verge of a breakthrough, striving to develop a revolutionary therapeutic for a complex disease. Read More
-
“The COVID-19 pandemic is helping us bridge the divide between virologists and immunologists”
An autoimmune disorder and natural curiosity led Dr. Louisa James to a fascinating career in immunology. Dr. James is currently… Read More
-
The role of point-of-care tests in tracking and curbing the COVID-19 pandemic
Coordinated strategies, efficient tracking, and vaccination are key to ensure a safe return to normal during the COVID-19 pandemic. But… Read More
-
Reinventing IgY biotherapeutics
An unorthodox project idea led Dr. Mara Freire, a researcher at CICECO – Aveiro Institute of Materials, from the Chemistry… Read More
-
How the environment shapes immune system development during pregnancy
Dr. Melanie Conrad, head of the Reproductive Immunology Lab at the Charité Medical University in Berlin, Germany, has dedicated her… Read More
-
How the phage display technology is boosting the production of valuable bispecific antibodies
Bispecific antibodies are valuable therapeutics due to their unique ability to engage different epitopes or antigens and thus modulate the… Read More
-
Is genetic immunization a one-size-fits-all solution to accelerate polyclonal antibody generation?
Polyclonal antibodies are valuable tools for research as secondary reagents or therapy as antivenom drugs. However, their production has largely… Read More
-
Can antibody therapeutics serve as effective tools to treat and alleviate aggressive rare diseases?
Although rare diseases are characterized by a generalized low incidence in the global population, collectively, over 7,000 different conditions affect… Read More
-
What makes antibody therapeutics uniquely fitted to fight autoimmune disorders?
Autoimmune disorders afflict almost 10% of the global population, with a particular incidence in young and middle-aged women. Despite the… Read More